HK392A - Pharmaceutical formulations with controlled release of the active substance - Google Patents

Pharmaceutical formulations with controlled release of the active substance Download PDF

Info

Publication number
HK392A
HK392A HK3/92A HK392A HK392A HK 392 A HK392 A HK 392A HK 3/92 A HK3/92 A HK 3/92A HK 392 A HK392 A HK 392A HK 392 A HK392 A HK 392A
Authority
HK
Hong Kong
Prior art keywords
active substance
controlled release
pharmaceutical formulations
pharmaceutically acceptable
substance
Prior art date
Application number
HK3/92A
Other languages
English (en)
Inventor
Zuger Othmar
Original Assignee
Novartis Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB858524135A external-priority patent/GB8524135D0/en
Priority claimed from GB858524653A external-priority patent/GB8524653D0/en
Priority claimed from GB858531419A external-priority patent/GB8531419D0/en
Priority claimed from GB868603097A external-priority patent/GB8603097D0/en
Priority claimed from GB868605037A external-priority patent/GB8605037D0/en
Application filed by Novartis Ag filed Critical Novartis Ag
Publication of HK392A publication Critical patent/HK392A/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841—Filling excipients; Inactive ingredients
    • A61K9/485—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841—Filling excipients; Inactive ingredients
    • A61K9/4858—Organic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841—Filling excipients; Inactive ingredients
    • A61K9/4866—Organic macromolecular compounds

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Inorganic Chemistry (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
HK3/92A 1985-10-01 1992-01-02 Pharmaceutical formulations with controlled release of the active substance HK392A (en)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
GB858524135A GB8524135D0 (en) 1985-10-01 1985-10-01 Darodipine compositions
GB858524653A GB8524653D0 (en) 1985-10-07 1985-10-07 Pharmaceutical formulations
GB858531419A GB8531419D0 (en) 1985-12-20 1985-12-20 Pindolol compositions
GB868603097A GB8603097D0 (en) 1986-02-07 1986-02-07 Pharmaceutical formulations
GB868605037A GB8605037D0 (en) 1986-02-28 1986-02-28 Oral pharmaceutical compositions

Publications (1)

Publication Number Publication Date
HK392A true HK392A (en) 1992-01-10

Family

ID=27516617

Family Applications (1)

Application Number Title Priority Date Filing Date
HK3/92A HK392A (en) 1985-10-01 1992-01-02 Pharmaceutical formulations with controlled release of the active substance

Country Status (20)

Country Link
KR (1) KR920008817B1 (enExample)
AT (1) AT402257B (enExample)
BE (1) BE905516A (enExample)
CA (1) CA1298784C (enExample)
CH (1) CH669524A5 (enExample)
DE (1) DE3632201C2 (enExample)
DK (1) DK170016B1 (enExample)
ES (1) ES2002508A6 (enExample)
FR (1) FR2589732B1 (enExample)
GR (1) GR862457B (enExample)
HK (1) HK392A (enExample)
HU (1) HU197201B (enExample)
IE (1) IE59589B1 (enExample)
IL (1) IL80182A (enExample)
LU (1) LU86615A1 (enExample)
NL (1) NL194822C (enExample)
NZ (1) NZ217732A (enExample)
PT (1) PT83456B (enExample)
SE (1) SE503222C2 (enExample)
SG (1) SG103391G (enExample)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6440457B1 (en) 1993-05-27 2002-08-27 Alza Corporation Method of administering antidepressant dosage form
US6855729B2 (en) * 2001-02-20 2005-02-15 Timothy G. Dinan Treatment of fibromyalgia and related fatigue syndromes using antagonists or partial agonists of 5HT1a receptors
TW200616681A (en) * 2004-10-05 2006-06-01 Recordati Ireland Ltd Lercanidipine capsules

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH630257A5 (en) * 1975-03-17 1982-06-15 Hoffmann La Roche Sustained release formulation
CH639659A5 (de) * 1978-12-18 1983-11-30 Sandoz Ag Neue 1,4-dihydropyridinderivate, deren herstellung und verwendung.
DD145004A3 (de) * 1978-09-25 1980-11-19 Reinhard Huettenrauch Verfahren zur herstellung fester a zneiformen
CA1146866A (en) * 1979-07-05 1983-05-24 Yamanouchi Pharmaceutical Co. Ltd. Process for the production of sustained release pharmaceutical composition of solid medical material
JPS6056122B2 (ja) * 1980-05-21 1985-12-09 塩野義製薬株式会社 徐放性製剤
GB2084017B (en) * 1980-09-18 1984-08-22 Sandoz Ltd Pharmaceutical compositions effective against coronary heat disease and hypertension
US4369172A (en) * 1981-12-18 1983-01-18 Forest Laboratories Inc. Prolonged release therapeutic compositions based on hydroxypropylmethylcellulose
CA1208558A (en) * 1982-10-07 1986-07-29 Kazuo Kigasawa Soft buccal
GB2154874B (en) * 1984-02-29 1987-11-04 Sandoz Ltd Bromoscriptine compositions
KR850700212A (ko) * 1984-03-21 1985-12-26 죠지 드모트 서방성 약제학적 캼셀제
JPS6124516A (ja) * 1984-07-12 1986-02-03 Fujisawa Pharmaceut Co Ltd 持続性錠剤

Also Published As

Publication number Publication date
NL8602370A (nl) 1987-05-04
SE503222C2 (sv) 1996-04-22
HUT44701A (en) 1988-04-28
NL194822C (nl) 2003-04-03
IL80182A (en) 1991-01-31
SE8604112D0 (sv) 1986-09-29
FR2589732A1 (fr) 1987-05-15
DE3632201A1 (de) 1987-04-02
ATA260486A (de) 1996-08-15
KR920008817B1 (ko) 1992-10-09
LU86615A1 (fr) 1987-04-02
CH669524A5 (enExample) 1989-03-31
KR870003777A (ko) 1987-05-04
FR2589732B1 (fr) 1989-07-13
IE862565L (en) 1987-04-01
DK170016B1 (da) 1995-05-01
PT83456A (en) 1986-10-01
SG103391G (en) 1992-01-17
NZ217732A (en) 1990-07-26
IL80182A0 (en) 1986-12-31
IE59589B1 (en) 1994-03-09
SE8604112L (sv) 1987-04-02
NL194822B (nl) 2002-12-02
DE3632201C2 (de) 1997-05-07
DK464686D0 (da) 1986-09-29
HU197201B (en) 1989-03-28
GR862457B (en) 1987-01-29
AT402257B (de) 1997-03-25
DK464686A (da) 1987-04-02
PT83456B (pt) 1989-05-12
BE905516A (fr) 1987-03-30
CA1298784C (en) 1992-04-14
ES2002508A6 (es) 1988-08-16

Similar Documents

Publication Publication Date Title
IE871981L (en) Programmed release formulation.
IE871584L (en) Sustained release capsule.
WO1994027557A3 (en) Pharmaceutical thermal infusion process
AU2766689A (en) New pharmaceutical formulations with programmed release
FI885460L (fi) Menetelmä suun kautta annettavaksi tarkoitetun, aktiiviyhdistettä kontrolloidusti vapauttavan farmaseuttisen formulaation valmistamiseksi
GR3005640T3 (enExample)
NO883667D0 (no) Kapsel for farmasoeytisk virksomme innholdsstoffer av en droge.
IE890921L (en) Pharmaceutical composition for systemic transdermal administration
IL106253A0 (en) Controlled release oral solid pharmaceutical dosage form and its preparation
AU1351788A (en) Slow-release pharmaceutical agent
AU3756797A (en) Controlled release pharmaceutical compositions for the oral administration containing nifedipine as active substance
AU1269488A (en) Phenoxycarboxylic acid and herbicide comprising it as active ingredient
HUT50334A (en) Process for producing arylpiperazinyl-alkilenephenyl-p-heterocycluc compounds, pharmaceutically acceptable acid addition salts thereof and pharmaceutical compositions comprising the compounds as active ingredient
HK392A (en) Pharmaceutical formulations with controlled release of the active substance
AU7536487A (en) A thymus derivative active after oral administration, methods of preparation and pharmaceutical compositions
CA2002337A1 (en) Controlled release flecainide acetate formulation
HK8994A (en) Medicament for treatment of pregnancy-induced hypertension
EP0367509A3 (en) Formulations
IT1214719B (it) Formulazioni farmaceutiche a liberazione prolungata della sostanza attiva

Legal Events

Date Code Title Description
PF Patent in force
PE Patent expired

Effective date: 20060928